How 340B In Big Health Systems is Hurting Patients

The 340B Drug Pricing Program is meant to provide patients in need or patients in poorer areas with access to prescription drugs at significantly discounted prices. Is that what the program accomplishes currently? Join Rose Gerber and her guests Ted Okon and Nicolas Ferreyros on October 12, 2022 at 12 p.m. ET, for a discussion about this federal program gone awry.

By |2023-02-10T14:45:15-05:00October 7, 2022|CPAN Advocacy Chats, CPAN Events|

The Psychosocial Impact of Cancer

As a national advocacy organization, CPAN works with other advocacy groups including CancerCare, founded in 1944, making it one of the oldest cancer advocacy organizations. CPAN has worked frequently with CancerCare and welcomed this month’s guest speaker, Lauren Chatalian, MSW, LCSW, the organization’s director of advocacy. In addition to explaining the work of CancerCare, this chat examined the emotional impact of a cancer diagnosis and the ongoing challenges patients with cancer face.

By |2023-02-10T14:45:15-05:00August 22, 2022|CPAN Advocacy Chats, CPAN Events|
Go to Top